You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

November 7, 2011

Procurement Contracts and Their Impact on Pharmaceutical Companies

PReMA Life

Concerns raised by the Thai pharmaceutical industry in recent years of alleged corrupt practices by employees of state hospitals, has led to the implementation of more stringent legislation to combat the problem of state funds seeping through a porous pharmaceutical procurement system.

Due to the fact that sales of pharmaceutical products to state hospitals by pharmaceutical companies have typically been conducted through procurement contracts, the existing system has long been open to possible abuse, which has stoked increasing concerns among legislators and administrators, both within the government and in state hospitals.

However, with the active enforcement of the US Foreign Corrupt Practices Act, and the recent implementation of the UK Bribery Act, foreign pharmaceutical companies are finally delving deeper into the practices of their sales teams and demanding more transparency.

The main concern is that companies without a strong culture of compliance may not attempt to implement these stricter sales rules, which would result in an unbalanced market.

Notification on Procurement Contracts

This objective of raising transparency in government and state agencies has led to the recent implementation of the Notification re: Rules and Procedures Concerning the Preparation and Disclosure of Revenue and Expenses Accounts of Projects in which Individuals or Juristic Entities Are Contractual Parties with Government Agencies (Notification), on August 11, 2011, by the National Anti-Corruption Commission (NACC). This notification arose as a direct result of the amendment of the Organic Act on Counter Corruption dated April 12, 2011.

The Notification, which will become effective on January 1, 2012, stipulates that private sector entities that enter into procurement contracts with government agencies will now be required to prepare, and electronically submit, annual revenue and expense accounts to the Revenue Department, as well as their Corporate Income Tax Return for juristic entities.

The Notification will significantly impact entities in the private sector that enter into government procurement contracts, including individuals, Thai companies, and foreign companies with a local presence. The definition of “government agencies” is quite broad and includes government hospitals such as Siriraj Hospital, King Chulalongkorn Memorial Hospital, and Bhumibol Adulyadej Hospital

One important factor introduced is that the threshold for reporting is set relatively low, as all government procurement contracts with a value of THB 500,000 or more will be subject to the disclosure requirement. Businesses will also be required to submit one revenue and expense account for each contract, and to retain supporting documents for at least five years.

The Notification also states that government agencies should set a condition requiring businesses that enter into procurement contracts to receive and make payment via a current account, with the exception of payments that do not exceed THB 30,000, which can be made in cash.

Government contracts executed before January 1, 2012, will not be subject to this new disclosure requirement. However, if any material amendments are made to such contracts after January 1, 2012, they will also be subject to the disclosure requirement.

Although failure to comply with the new disclosure requirement does not entail criminal penalties, the sanction imposed under the Notification is commercially severe: violators will be disqualified from entering into new procurement contracts with government agencies. In addition, failure to comply with the reporting requirement, or incorrect reporting, could result in scrutiny by the NACC, the Revenue Department, and other relevant government authorities.

The new reporting requirement will place a substantial burden on the private sector, because it requires a separate detailed report for each contract, and contract values exceeding the low threshold of THB 500,000 will subject entities to the reporting requirement.

Impact on Pharmaceutical Companies

Pharmaceutical companies frequently enter into procurement contracts with government agencies, as defined in the Notification. Since most of these procurement contracts exceed the threshold of THB 500,000, pharmaceutical companies will now be required to provide detailed information for each procurement contract. When pharmaceutical companies provide discounts or donations to hospitals, these are sometimes not officially part of the procurement contract. It is therefore questionable whether these items need to be disclosed under the Notification.

Nonetheless, foreign companies must carefully assess the legality of such discounts or donations in pharmaceutical procurement contracts and the impact of the Notification on these aspects of procurement.

The approach adopted by the pharmaceutical company’s headquarters is also an important factor that must be taken into consideration. In any event, the company must ensure legality by implementing measures to lower the possible risk of action being taken by Thai regulators as well as foreign governments. In principle, the firm must at least ensure that a receipt is issued, the recipient is not an individual, and also verify that the money is used by the hospitals, etc.

The worldwide legal framework on corruption is changing, leading to more harmonized rules. However, the environment still remains a difficult one for companies to operate in, because some practices are strongly ingrained in some countries. Thus, despite the introduction of the new regulations in Thailand, the extent to which the new requirements will be implemented by the new government still remains uncertain.

RELATED INSIGHTS​ 

September 28, 2026
On July 22, 2026, the government of Vietnam issued Decree No. 292/2026/ND-CP detailing the implementation of the Law on Foreign Trade Management (Decree 292). Decree 292 came into effect on September 5, 2026, replacing Decree No. 69/2018/NND-CP, and introduces several important changes to Vietnam’s foreign trade regime. Of particular relevance is the addition to the list of goods prohibited from importation of “products and goods extracted, produced, or manufactured wholly or partly through forced labor by enterprises, countries, or territories in accordance with relevant international treaties to which the Socialist Republic of Vietnam is a party.” This new prohibition introduces forced-labor considerations into Vietnam’s import compliance framework and may have practical implications for how businesses manage related risks across their operations and supply chains. Implementation of the New Prohibition According to Decree 292, the minister or head of the relevant ministerial-level agency is responsible for publishing the detailed list and corresponding harmonized system (HS) codes for each category of goods prohibited from export or import under its purview. Goods involving forced labor fall under the purview of the Ministry of Home Affairs. However, as of the date of this article, no corresponding list has been published specifying the goods to which the forced-labor prohibition applies, leaving businesses without official guidance on how the prohibition will be applied or enforced in practice. Nevertheless, this absence does not suspend the prohibition’s application. As Decree 292 has already taken effect, goods involving forced labor remain subject to the general legal framework applicable to goods prohibited from importation. In particular, Decree 169/2026/ND-CP provides for administrative penalties for the importation or transportation of prohibited goods into Vietnam. Depending on the nature and circumstances of the violation, criminal liability may also arise under the Criminal Code. In practice, enforcement is likely to depend on the
August 20, 2026
As part of its membership in Lex Mundi, Tilleke & Gibbins has released the latest edition of its Guide to Doing Business in Thailand, providing an overview of the legal, regulatory, and commercial considerations for companies establishing or expanding operations in Thailand. The 2026 edition offers practical insight into the country’s business environment, investment framework, and operational requirements. The guide covers a wide range of topics relevant to foreign and domestic investors, including: Investment incentives and promotion schemes Financial facilities and banking regulations Exchange controls and money transfers Import and export regulations Business structures and incorporation options Requirements for establishing a business Operational and compliance considerations Business cessation and insolvency procedures Employment and labor laws Taxation Immigration and visa requirements Prepared by Tilleke & Gibbins lawyers across multiple practice areas, the publication outlines key aspects of doing business in Thailand, including foreign investment restrictions, regulatory compliance obligations, corporate structures, employment requirements, and recent legal and economic developments affecting investors. The publication forms part of Lex Mundi’s Country Guides series, a global collection of jurisdiction-specific reference materials prepared by member firms around the world. Together, these guides help companies evaluate opportunities, compare regulatory environments, and plan international business activities across multiple markets. The full Guide to Doing Business in Thailand 2026 is available through the button below.
August 18, 2026
The Bank of Thailand (BOT) is seeking public comment on proposed amendments that would significantly expand know-your-customer (KYC) and customer due diligence (CDD) requirements for cash-related transactions at financial institutions (FIs) and specialized financial institutions (SFIs). Released on August 5, 2026, the proposed regulation would supersede BOT Notification No. 16/2569, which focused primarily on cash withdrawal transactions. The public comment period is open through September 3, 2026. The amendments reflect concerns that FIs and SFIs may be used to facilitate the movement, concealment, and conversion of criminal proceeds, potentially damaging institutional operations and public confidence in the financial system. Expanded Scope of Covered Transactions The most significant change is the broadening of the definition of “cash-related transactions.” Previously, the regulation covered only cash withdrawals and uncrossed check withdrawals. The amended regulation extends coverage to include: Cash deposits, check deposits, or receipt of funds from the public not in the form of deposit accounts; Thai baht (THB) banknote exchange (different denominations); Receipt of cash for issuing checks and drafts; and Purchase, sale, or exchange of foreign banknotes. Mandatory Identity Verification and Risk Management For all cash-related transactions, FIs and SFIs must require customers, or authorized or delegated persons, to present identification or verify their identity before every transaction, including one-time (walk-in) transactions. Specific identification requirements vary by transaction type, customer nationality, and channel (branch vs. electronic). FIs and SFIs must also establish comprehensive risk management processes and procedures for cash-related transactions. These requirements include identifying customers or authorized representatives in accordance with transaction-specific verification standards, analyzing customer behavior, implementing risk-management measures proportionate to the customer’s risk profile, and recording abnormal behavior in relevant systems. The BOT also encourages institutions to proactively guide customers toward transaction channels that offer greater traceability than cash. For corporate customers in high-risk business sectors—including foreign
July 14, 2026
Tilleke & Gibbins has contributed the Thailand and Vietnam chapters to Investigations in Southeast Asia, a comprehensive guide published by Drew Network Asia (DNA). The resource provides a practical overview of anticorruption laws, corporate investigations, and compliance frameworks across six key Southeast Asian jurisdictions. Designed for in-house counsel, compliance officers, and risk management professionals, the guide offers actionable insights for navigating complex cross-border regulatory challenges and establishing effective, regionally coordinated compliance and investigation strategies. The guide begins with a regional perspective on enforcement trends and cross-border cooperation initiatives. Jurisdiction-specific chapters follow a standardized structure—covering primary corruption offenses, enforcement authorities, corporate liability, investigation procedures and dawn raids, whistleblower protections, and recommended compliance measures. In addition to country-by-country analysis, the publication highlights best practices for conducting internal investigations, managing digital evidence, and handling parallel proceedings involving multiple regional or international regulators. The guide serves as a practical reference for organizations operating in Southeast Asia. Because legal and regulatory risks depend on specific industry sectors and operational contexts, readers seeking tailored advice are encouraged to contact the authors listed in each chapter. The full guide is available for download through the button below or directly from the DNA website.